BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1086108)

  • 1. Human lymphocyte motility: normal characteristics and anomalous behavior of chronic lymphocytic leukemia cells.
    Jarvis SC; Snyderman R; Cohen HJ
    Blood; 1976 Nov; 48(5):717-29. PubMed ID: 1086108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lymphocyte surface immunoglobulin capping. Normal characteristics and anomalous behavior of chronic lymphocytic leukemic lymphocytes.
    Cohen HJ
    J Clin Invest; 1975 Jan; 55(1):84-93. PubMed ID: 1088910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anomalous function of vimentin in chronic lymphocytic leukemia lymphocytes.
    Stark RS; Liebes LF; Shelanski ML; Silber R
    Blood; 1984 Feb; 63(2):415-20. PubMed ID: 6537890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenylate cyclase in thymus-derived and bone marrow-derived lymphocytes from normal donors and patients with chronic lymphocytic leukemia.
    Mendelsohn J; Nordberg J
    J Clin Invest; 1979 Jun; 63(6):1124-32. PubMed ID: 221534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulation of B lymphocyte colony formation by T cell subsets in patients with chronic lymphocytic leukemia.
    Fernandez LA; MacSween JM; Langley GR
    Blood; 1986 Feb; 67(2):294-8. PubMed ID: 2935205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of locomotion in lymphocyte migration.
    Freitas AA; Bognacki J
    Immunology; 1979 Feb; 36(2):247-55. PubMed ID: 220182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety.
    Ayanlar-Batuman O; Ebert E; Hauptman SP
    Blood; 1986 Feb; 67(2):279-84. PubMed ID: 2935203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The defect of lymphocyte locomotion in chronic lymphocytic leukaemia: studies of polarization and growth-dependent locomotion.
    Wilkinson PC; Islam LN; Sinclair D; Dagg JH
    Clin Exp Immunol; 1988 Mar; 71(3):497-501. PubMed ID: 3383451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of reovirus with cell surface receptors. III. Reovirus type 3 induces capping of viral receptors on murine lymphocytes.
    Epstein RL; Powers ML; Weiner HL
    J Immunol; 1981 Nov; 127(5):1800-3. PubMed ID: 6975296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Y+- and L-system amino acid transport in normal and chronic lymphocytic leukemia lymphocytes: photoinhibition by fluoronitrophenylazide.
    Segel GB; Tometsko AM; Lichtman MA
    Arch Biochem Biophys; 1985 Nov; 242(2):347-54. PubMed ID: 3933420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capping of peripheral blood lymphocyte C3 receptors in chronic lymphocytic leukemia: relationship to chemotherapy.
    Gormus BJ; Basara ML; Oken MM; Leech SH; Kaplan ME
    Int J Cancer; 1981 Feb; 27(2):151-9. PubMed ID: 7287213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lymphocytic leukemia lymphocytes: membrane anomalies and H2O2 vulnerability.
    Silber R; Stahl RL; Farber CM; Kanganis D; Astrow A; Liebes LF
    Blood Cells; 1984; 10(2-3):233-9. PubMed ID: 6336165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes.
    Faguet GB
    J Clin Invest; 1979 Jan; 63(1):67-74. PubMed ID: 153914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte response to pokeweed mitogen in chronic lymphocytic leukemia.
    Lamberson HV; Davey FR; Schreck CM; Zamkoff K; Kurec AS
    Cancer; 1984 Jun; 53(11):2481-6. PubMed ID: 6608985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface markers and other characteristics of the lymphocyte in chronic lymphocytic leukemia.
    Bentwich Z; Polliack A; Douglas SD
    Isr J Med Sci; 1976; 12(4-5):304-22. PubMed ID: 1084879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic dehydrogenase in normal and leukemia lymphocyte subpopulations: evidence for the presence of abnormal T cells and B cells in chronic lymphocytic leukemia.
    Rambotti P; Davis S
    Blood; 1981 Feb; 57(2):324-7. PubMed ID: 6969615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective helper function of purified T4 cells and excessive suppressor activity of purified T8 cells in patients with B-cell chronic lymphocytic leukemia. T4 suppressor effector cells are present in certain patients.
    Kunicka JE; Platsoucas CD
    Blood; 1988 Jun; 71(6):1551-60. PubMed ID: 2967096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoplastic anemia in B cell chronic lymphocytic leukemia: evolution of T cell-mediated suppression of erythropoiesis in early-stage and late-stage disease.
    Mangan KF; D'Alessandro L
    Blood; 1985 Sep; 66(3):533-41. PubMed ID: 3161561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD5 and CD21 molecules are a functional unit in the cell/substrate adhesion of B-chronic lymphocytic leukemia cells.
    Bergui L; Tesio L; Schena M; Riva M; Malavasi F; Schulz T; Marchisio PC; Caligaris-Cappio F
    Eur J Immunol; 1988 Jan; 18(1):89-96. PubMed ID: 3278912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.